1Rustan, AC, Hustvedt, BE & Drevon, CA (1998) Postprandial decrease in plasma unesterified fatty acids during n-3 fatty acid feeding is not caused by accumulation of fatty acids in adipose tissue. Biochim Biophys Acta 1390, 245–257.
2Harris, WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, Suppl., 1645S–1654S.
3Harris, WS (1997) n-3 Fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr 65, Suppl., 1611S–1616S.
4Rustan, AC, Nossen, JO, Osmundsen, H, et al. (1988) Eicosapentaenoic acid inhibits cholesterol esterification in cultured parenchymal cells and isolated microsomes from rat liver. J Biol Chem 263, 8126–8132.
5Nossen, JO, Rustan, AC, Gloppestad, SH, et al. (1986) Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes. Biochim Biophys Acta 879, 56–65.
6Rustan, AC, Nossen, JO, Christiansen, EN, et al. (1988) Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res 29, 1417–1426.
7Ukropec, J, Reseland, JE, Gasperikova, D, et al. (2003) The hypotriglyceridemic effect of dietary n-3 FA is associated with increased β-oxidation and reduced leptin expression. Lipids 38, 1023–1029.
8Rustan, AC, Hustvedt, BE & Drevon, CA (1993) Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat. J Lipid Res 34, 1299–1309.
9Yusuf, S, Hawken, S, Ounpuu, S, et al. (2005) Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case–control study. Lancet 366, 1640–1649.
10Lafontan, M & Berlan, M (2003) Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 24, 276–283.
11Belzung, F, Raclot, T & Groscolas, R (1993) Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 264, R1111–R1118.
12Hill, JO, Peters, JC, Lin, D, et al. (1993) Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord 17, 223–236.
13Parrish, CC, Pathy, DA & Angel, A (1990) Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism 39, 217–219.
14Cannon, B & Nedergaard, J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84, 277–359.
15Dyerberg, J (1989) Coronary heart disease in Greenland Inuit: a paradox. Implications for Western diet patterns. Arctic Med Res 48, 47–54.
16Bligh, EG & Dyer, WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911–917.
17Wergedahl, H, Liaset, B, Gudbrandsen, OA, et al. (2004) Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134, 1320–1327.
18Murano, I, Zingaretti, MC & Cinti, S (2005) The adipose organ of SV129 mice contains a prevalence of brown adipocytes and shows plasticity after cold exposure. Adipocytes 2, 121–130.
19Association of Official Analytical Chemists (1990) Official Methods of Analysis, 15th ed.Arlington,VA: AOAC.
20Jensen, J, Jebens, E, Brennesvik, EO, et al. (2006) Muscle glycogen inharmoniously regulates glycogen synthase activity, glucose uptake, and proximal insulin signaling. Am J Physiol Endocrinol Metab 290, E154–E162.
21Berge, RK, Flatmark, T & Osmundsen, H (1984) Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators. Eur J Biochem 141, 637–644.
22Gudbrandsen, OA, Wergedahl, H, Liaset, B, et al. (2005) Dietary proteins with high isoflavone content or low methionine-glycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats. Br J Nutr 94, 321–330.
23Madsen, L, Froyland, L, Dyroy, E, et al. (1998) Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. J Lipid Res 39, 583–593.
24Small, GM, Burdett, K & Connock, MJ (1985) A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227, 205–210.
25Caesar, R & Drevon, CA (2008) Pancreatic contamination of mesenteric adipose tissue samples can be avoided by adjusted dissection procedures. J Lipid Res 49, 1588–1594.
26Yusuf, S, Hawken, S, Ounpuu, S, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364, 937–952.
27Pais, P, Pogue, J, Gerstein, H, et al. (1996) Risk factors for acute myocardial infarction in Indians: a case–control study. Lancet 348, 358–363.
28Dagenais, GR, Yi, Q, Mann, JF, et al. (2005) Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 149, 54–60.
29Kusunoki, M, Tsutsumi, K, Hara, T, et al. (2003) Ethyl icosapentate (omega-3 fatty acid) causes accumulation of lipids in skeletal muscle but suppresses insulin resistance in OLETF rats. Metabolism 52, 30–34.
30Pérez-Matute, P, Perez-Echarri, N, Martinez, JA, et al. (2007) Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-α. Br J Nutr 97, 389–398.
31Kelly, IE, Han, TS, Walsh, K, et al. (1999) Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 22, 288–293.
32Carey, DG, Cowin, GJ, Galloway, GJ, et al. (2002) Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected]. Obes Res 10, 1008–1015.
33Fissoune, R, Pellet, N, Chaabane, L, et al. (2004) Evaluation of adipose tissue distribution in obese fa/fa Zucker rats by in vivo MR imaging: effects of peroxisome proliferator-activated receptor agonists. MAGMA 17, 229–235.
34Xu, HE, Lambert, MH, Montana, VG, et al. (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3, 397–403.
35Forman, BM, Chen, J & Evans, RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A 94, 4312–4317.
36de Souza, CJ, Eckhardt, M, Gagen, K, et al. (2001) Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50, 1863–1871.
37Chambrier, C, Bastard, JP, Rieusset, J, et al. (2002) Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor γ. Obes Res 10, 518–525.
38Aas, V, Rokling-Andersen, MH, Kase, ET, et al. (2005) Eicosapentaenoic acid (20 : 5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells. J Lipid Res 47, 366–374.
39Semple, RK, Chatterjee, VK & O'Rahilly, S (2006) PPARγ and human metabolic disease. J Clin Invest 116, 581–589.
40Guan, HP, Li, Y, Jensen, MV, et al. (2002) A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 8, 1122–1128.
41Tan, GD, Debard, C, Tiraby, C, et al. (2003) A ‘futile cycle’ induced by thiazolidinediones in human adipose tissue? Nat Med 9, 811–812.
42Halvorsen, B, Rustan, AC, Madsen, L, et al. (2001) Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats. Ann Nutr Metab 45, 30–37.
43Froyland, L, Madsen, L, Vaagenes, H, et al. (1997) Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J Lipid Res 38, 1851–1858.
44Opal, SM & DePalo, VA (2000) Anti-inflammatory cytokines. Chest 117, 1162–1172.
45Nielsen, AR & Pedersen, BK (2007) The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 32, 833–839.
46Pedersen, BK, Akerstrom, TC, Nielsen, AR, et al. (2007) Role of myokines in exercise and metabolism. J Appl Physiol 103, 1093–1098.
47Einstein, FH, Atzmon, G, Yang, XM, et al. (2005) Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 54, 672–678.
48Fain, JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74, 443–477.